Related Experiment Videos
Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study
V S Mattay1, K F Berman, J L Ostrem
1Clinical Brain Disorders Branch, Intramural Research Porgram, National Institute of Mental Health, National Institutes of Health Neuroscience Center at Saint Elizabeth's, Washington, DC 20032, USA.
Summary
Dextroamphetamine enhances cognitive task performance by focusing neural activity in specific brain regions, increasing the signal-to-noise ratio for cognitive tasks. This drug selectively augments relevant brain activity, improving cognitive efficiency.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Pharmacology
Background:
- Monoamines are known to enhance behavior-evoked neural activity, improving the signal-to-noise ratio.
- Dextroamphetamine, an indirect monoaminergic agonist, has been studied for its effects on cognitive function.
Purpose of the Study:
- To investigate the effects of dextroamphetamine on cognitively evoked neural activity.
- To determine if dextroamphetamine enhances task-specific brain activation and improves cognitive efficiency.
Main Methods:
- Eight healthy subjects underwent positron-emission tomography (PET) to measure regional cerebral blood flow (rCBF).
- Subjects received dextroamphetamine (0.25 mg/kg) or placebo in a double-blind, counterbalanced design.
- rCBF was measured during abstract reasoning tasks (Wisconsin Card Sorting Task, Ravens Progressive Matrices) and corresponding sensorimotor control tasks.
Main Results:
- Dextroamphetamine demonstrated double dissociations in task-dependent rCBF activation in specific brain regions.
- In the left inferior frontal gyrus, dextroamphetamine increased rCBF during WCST but decreased it during RPM.
- In the right hippocampus, blood flow decreased during WCST but increased during RPM.
Conclusions:
- Dextroamphetamine selectively focuses neural activity, highlighting task-specific neural networks.
- This cognitively specific signal augmentation by dextroamphetamine may explain observed improvements in cognitive efficiency.